| 51 |
23502672 | Clinical profile and outcome of infantile onset diabetes mellitus in southern India. | 2013 Aug |
1 |
| 52 |
24324494 | Pharmacogenetics of oral antidiabetic drugs. | 2013 |
3 |
| 53 |
21989597 | Heterozygous ABCC8 mutations are a cause of MODY. | 2012 Jan |
3 |
| 54 |
22118705 | Treating diabetes today: a matter of selectivity of sulphonylureas. | 2012 Jan |
1 |
| 55 |
22433315 | Cardiovascular effects of antidiabetic agents: focus on blood pressure effects of incretin-based therapies. | 2012 May-Jun |
1 |
| 56 |
22533711 | ABCC8 polymorphisms are associated with triglyceride concentration in type 2 diabetics on sulfonylurea therapy. | 2012 Aug |
6 |
| 57 |
22768668 | Improved long-term glucose control in neonatal diabetes mellitus after early sulfonylurea allergy. | 2012 |
1 |
| 58 |
22842804 | Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene. | 2012 Aug |
1 |
| 59 |
22996131 | Monogenic models: what have the single gene disorders taught us? | 2012 Dec |
1 |
| 60 |
21109997 | Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation. | 2011 Feb |
1 |
| 61 |
21273495 | The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. | 2011 Mar |
1 |
| 62 |
21796147 | A pathway to insulin independence in newborns and infants with diabetes. | 2011 Aug |
1 |
| 63 |
21993633 | Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. | 2011 Dec |
1 |
| 64 |
22020219 | Mechanism of KATP hyperactivity and sulfonylurea tolerance due to a diabetogenic mutation in L0 helix of sulfonylurea receptor 1 (ABCC8). | 2011 Nov 16 |
3 |
| 65 |
22124439 | Management of diabetes mellitus in infants. | 2011 Nov 29 |
1 |
| 66 |
22308870 | Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant. | 2011 |
1 |
| 67 |
24843477 | Genetics and pathophysiology of neonatal diabetes mellitus. | 2011 Jun 5 |
1 |
| 68 |
21142918 | ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas. | 2010 Dec |
1 |
| 69 |
23226049 | The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes. | 2010 |
2 |
| 70 |
19139106 | Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1. | 2009 Mar 13 |
1 |
| 71 |
19323963 | Pharmacogenetics in diabetes. | 2009 Apr |
2 |
| 72 |
19342262 | Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes. | 2009 Jun |
1 |
| 73 |
19587354 | Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel. | 2009 Oct |
1 |
| 74 |
19799532 | Influence of genetic polymorphisms on the pharmacokinetics and pharmaco-dynamics of sulfonylurea drugs. | 2009 Jul |
3 |
| 75 |
18025408 | Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. | 2008 Feb |
5 |
| 76 |
18032110 | Drugs acting on SUR1 to treat CNS ischemia and trauma. | 2008 Feb |
1 |
| 77 |
18301398 | Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. | 2008 Apr |
1 |
| 78 |
17110465 | Defining a binding pocket for sulfonylureas in ATP-sensitive potassium channels. | 2007 Jan |
3 |
| 79 |
17213273 | Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. | 2007 Apr |
1 |
| 80 |
17349054 | Neonatal diabetes mellitus: a disease linked to multiple mechanisms. | 2007 Mar 9 |
1 |
| 81 |
17575084 | Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue. | 2007 Sep |
2 |
| 82 |
17931842 | [Neonatal diabetes: a disease linked to multiple mechanisms]. | 2007 Nov |
1 |
| 83 |
17986830 | Management of neonatal and infancy-onset diabetes mellitus. | 2007 |
1 |
| 84 |
16556760 | Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes. | 2006 Jun |
1 |
| 85 |
16885549 | Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. | 2006 Aug 3 |
1 |
| 86 |
16956886 | Sulfonylureas correct trafficking defects of disease-causing ATP-sensitive potassium channels by binding to the channel complex. | 2006 Nov 3 |
4 |
| 87 |
17296510 | Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences. | 2006 Dec |
1 |
| 88 |
15652236 | Role of two adjacent cytoplasmic tyrosine residues in MRP1 (ABCC1) transport activity and sensitivity to sulfonylureas. | 2005 Feb 1 |
2 |
| 89 |
15659079 | Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients. | 2005 Jan |
2 |
| 90 |
14707124 | Sulfonylureas correct trafficking defects of ATP-sensitive potassium channels caused by mutations in the sulfonylurea receptor. | 2004 Mar 19 |
3 |
| 91 |
15561897 | Toward linking structure with function in ATP-sensitive K+ channels. | 2004 Dec |
2 |
| 92 |
12566087 | Inhibition of ATP-sensitive K(+)-channels by a sulfonylurea analogue with a phosphate group. | 2003 Feb 15 |
1 |
| 93 |
12879777 | [Polymorphism of the sulfonylurea receptor gene in type 2 diabetes mellitus]. | 2003 Feb |
3 |
| 94 |
12939732 | Ischemia in type 2 diabetes: tissue selectivity of sulfonylureas and clinical implications. | 2003 Aug |
2 |
| 95 |
11825905 | Assembly limits the pharmacological complexity of ATP-sensitive potassium channels. | 2002 Apr 19 |
1 |
| 96 |
12118200 | Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects. | 2002 Jul |
3 |
| 97 |
12475777 | Sulfonylurea stimulation of insulin secretion. | 2002 Dec |
1 |
| 98 |
12703060 | [Molecular mechanisms of insulin secretion]. | 2002 Dec |
1 |
| 99 |
11272143 | Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations. | 2001 Feb |
1 |
| 100 |
11343328 | Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study. | 2001 Jun 1 |
1 |